MedTrace Logo

PrOgnosis Following Esophageal FisTula FormaTion in Pts Undergoing CathetER Ablation for AF Study

NCT05273645 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 138

Last updated 2024-09-19

No results posted yet for this study

Summary

Pulmonary vein isolation emerged as an effective and safe strategy to treat atrial fibrillation patients. Atrio-oesophageal fistula (AOF) represents a rare but devastating complication of AF ablation procedure. This complication (0.016-0.07%) requires an international effort to allow for better understanding of the factors contributing to its occurrence and the best management strategies. A worldwide, retrospective, multicenter registry focusing on the incidence, diagnosis and management of this complication.

Conditions

Sponsors & Collaborators

  • University of Luebeck

    lead OTHER

Principal Investigators

  • Roland R Tilz · Universitaet Luebeck

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-31
Primary Completion
2023-02-28
Completion
2024-02-28

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05273645 on ClinicalTrials.gov